Biolotus Biotech supports the development of innovative products across key therapeutic areas such as cancer,  immune diseases, life threatening hemorrhages and fungal infections, fostering profitable, sustainable and strategic partnerships

Our R&D pipeline comprehend:

Innovative projects to answer to new challenges in the medical field

• Genetics (genome engineering)
• Proprietary antifungal for aspergillosis (pulmonary delivery)
• Flashclot
• Mousticide
• Market cooperation and technology transfer
• Therapeutic enzymes (biosimilars)
• Monoclonal antibodies (biosimilars)
• Diagnostic tools

Biolotus Biotech focuses on internalizing state of art production technologies for biopharmaceuticals, ensuring high quality standards